December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mohammed Shahait: Our new study “Termination of Urologic Cancer Trials”
Jan 19, 2024, 19:10

Mohammed Shahait: Our new study “Termination of Urologic Cancer Trials”

Mohammed Shahait, Clinical Instructor of Urology at The University of Pennsylvania and The University of Pittsburgh Medical Center, shared on X/Twitter:

Our new study “Termination of Urologic Cancer Trials” at JCO Global Oncology.

25% termination rate.

Main cause: Low patient accrual.
Risk factors: University funding, single-center, small sample.”

Additional information.

Source: Mohammed Shahait/X